RecruitingNot ApplicableNCT06908629

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Addressing Social Determinants of Health (SDOH) Among Metro Detroit Cancer Survivors: A Pilot Feasibility Study (The Resource Ready Study)

Sponsor

Barbara Ann Karmanos Cancer Institute

Enrollment

120 participants

Start Date

Sep 3, 2024

Study Type

INTERVENTIONAL

Conditions

Cancer Cancer Survivors Neuroendocrine Tumors Gastrointestinal Cancers Multiple Myeloma, Neoplasms

Summary

The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer diagnosis and reside in Metro Detroit, Michigan. Main questions to answer are: * Can we have a completion rate of at least 80% of participants filling out the screening tool? * Can we determine procedures for patient referrals based on social needs * Can we implement brief interventions based on food access and digital inclusion (ensuring everyone has access to the digital technologies they need to participate in society)

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a program to help cancer survivors in the Metro Detroit area address social needs — such as food insecurity, housing, and transportation — that can affect health and recovery after cancer treatment. **You may be eligible if...** - You are 18 or older - You have had or currently have a cancer diagnosis (any type) - You live in the greater Detroit area (Wayne, Oakland, or Macomb County) - You are proficient in English - You are actively receiving care at a Karmanos Cancer Institute clinic, OR you are a past patient who has reported food insecurity and agreed to future contact **You may NOT be eligible if...** - There are no exclusion criteria listed — most cancer survivors in the area may be eligible Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.